Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

(2022) Max E. Adrichem et al.   BRAIN

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

(2022) Yueran Cui et al.   Frontiers in Molecular Neuroscience

Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy

(2022) Mahima Kapoor et al.   EUROPEAN JOURNAL OF NEUROLOGY

Elevated levels of NLRP3 inflammasome in serum of patients with chronic inflammatory demyelinating polyradiculoneuropathy are associated with disease severity

(2021) Zhi-Jie Zhou et al.   NEUROLOGICAL SCIENCES

NOD-like receptors in autoimmune diseases

(2021) Li Chen et al.   ACTA PHARMACOLOGICA SINICA

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)

(2021) S. R. M. Bus et al.   Trials

Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients

(2021) Yuki Fukami et al.   JOURNAL OF NEUROLOGY

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

(2021) Peter Y. K. Van den Bergh et al.   EUROPEAN JOURNAL OF NEUROLOGY

Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice

(2021) Jeffrey A. Allen et al.   Expert Review of Neurotherapeutics

The plasma peptides of Alzheimer’s disease

(2021) Angelique Florentinus-Mefailoski et al.   Clinical Proteomics

IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies

(2021) Joshua Bennett et al.   CURRENT OPINION IN HEMATOLOGY

Role of the NLRP3 inflammasome in autoimmune diseases

(2020) Zhe Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Kinase inhibition in autoimmunity and inflammation

(2020) Ali A. Zarrin et al.   NATURE REVIEWS DRUG DISCOVERY

The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets

(2020) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy

(2019) Gwen G. A. Lieverloo et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

(2019) Nathan Kelley et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Critical Roles of Glutaredoxin in Brain Cells—Implications for Parkinson's Disease

(2018) Olga Gorelenkova Miller et al.   ANTIOXIDANTS & REDOX SIGNALING

Extracellular vesicle–mediated transfer of constitutively active MyD88L265Pengages MyD88wtand activates signaling

(2018) Mateja Manček-Keber et al.   BLOOD

International chronic inflammatory demyelinating polyneuropathy Outcome Study (ICOS): protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome

(2018) Carina Bunschoten et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Distal hereditary motor neuropathy type 7B with Dynactin 1 mutation

(2016) Sun Hee Hwang et al.   Molecular Medicine Reports

Redoxins in peripheral neurons after sciatic nerve injury

(2015) Lucie Valek et al.   FREE RADICAL BIOLOGY AND MEDICINE

Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy

(2015) Minako Beppu et al.   JOURNAL OF NEUROIMMUNOLOGY

Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy

(2015) Anna Hiu Yi Wong et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

(2014) Erika Assarsson et al.   PLoS One

Deregulated NLRP3 and NLRP1 Inflammasomes and Their Correlations with Disease Activity in Systemic Lupus Erythematosus

(2013) Q. Yang et al.   JOURNAL OF RHEUMATOLOGY

IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation

(2013) K.-M. Lin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies

(2011) S. I. van Nes et al.   NEUROLOGY

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher

(2010) P. Y. K. Van den Bergh et al.   EUROPEAN JOURNAL OF NEUROLOGY

A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy

(2010) Karine Viala et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Cytosolic 5′-nucleotidase III (NT5C3): gene sequence variation and functional genomics

(2009) Pinar Aksoy et al.   Pharmacogenetics and Genomics

Knockdown of Cytosolic Glutaredoxin 1 Leads to Loss of Mitochondrial Membrane Potential: Implication in Neurodegenerative Diseases

(2008) Uzma Saeed et al.   PLoS One